Study of Trilipix Effects on Lipids and Arteries

Summary

Fibrates reduce atherosclerosis and cardiovascular disease events. A major mechanism of this benefit appears to be their ability to raise plasma high density lipoprotein cholesterol (HDL-C), especially in patients with high triglyceride levels. This study will investigate the effects of the addition of Trilipix (fenofibric acid) versus placebo to ongoing statin treatment on high density lipoprotein (HDL) composition and arterial function in subjects with insulin resistance.

Timeline

Start

2009-11

Primary completion

2011-03

Completion

2011-03

Outcome

Outcome not reported

Stopped (Business): “Collaborator/corporate sponsor withdrew funding and permission to continue.”

Drugs

Indications